2024 Q2 Form 10-Q Financial Statement

#000089353824000030 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $634.6M $559.9M
YoY Change 15.22% -2.38%
Cost Of Revenue $136.6M $137.4M
YoY Change -6.16% -3.49%
Gross Profit $497.9M $422.5M
YoY Change 22.9% -2.01%
Gross Profit Margin 78.47% 75.46%
Selling, General & Admin $31.11M $30.18M
YoY Change 13.13% 9.07%
% of Gross Profit 6.25% 7.14%
Research & Development $17.09M $18.58M
YoY Change 14.26% 0.83%
% of Gross Profit 3.43% 4.4%
Depreciation & Amortization $179.7M $166.2M
YoY Change 13.82% 7.78%
% of Gross Profit 36.08% 39.33%
Operating Expenses $230.7M $216.0M
YoY Change 11.17% 2.62%
Operating Profit $279.4M $178.4M
YoY Change 41.33% -34.42%
Interest Expense $21.81M $21.87M
YoY Change -308.2% -2.61%
% of Operating Profit 7.81% 12.26%
Other Income/Expense, Net -$23.00K -$24.00K
YoY Change -100.48% -100.54%
Pretax Income $263.9M $163.3M
YoY Change 37.46% -35.74%
Income Tax $53.59M $32.07M
% Of Pretax Income 20.31% 19.64%
Net Earnings $210.3M $131.2M
YoY Change 40.31% -33.92%
Net Earnings / Revenue 33.14% 23.43%
Basic Earnings Per Share $1.83 $1.13
Diluted Earnings Per Share $1.82 $1.13
COMMON SHARES
Basic Shares Outstanding 115.0M shares 115.7M shares
Diluted Shares Outstanding 115.7M shares 116.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $487.9M $506.3M
YoY Change 28.98% 5.94%
Cash & Equivalents $487.9M $506.3M
Short-Term Investments
Other Short-Term Assets $47.26M $45.06M
YoY Change -43.02% -50.26%
Inventory
Prepaid Expenses
Receivables $239.1M $241.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $774.2M $793.0M
YoY Change 14.03% 4.86%
LONG-TERM ASSETS
Property, Plant & Equipment $5.662B $5.514B
YoY Change 8.23% 9.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $111.4M $84.62M
YoY Change 35.14% 22.71%
Total Long-Term Assets $5.883B $5.605B
YoY Change 10.71% 9.61%
TOTAL ASSETS
Total Short-Term Assets $774.2M $793.0M
Total Long-Term Assets $5.883B $5.605B
Total Assets $6.657B $6.398B
YoY Change 11.09% 9.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $563.8M $496.4M
YoY Change 6.28% -4.96%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $601.8M $536.1M
YoY Change 6.7% -4.81%
LONG-TERM LIABILITIES
Long-Term Debt $1.577B $1.576B
YoY Change 0.2% 0.2%
Other Long-Term Liabilities $65.77M $65.26M
YoY Change -63.73% 9.42%
Total Long-Term Liabilities $2.211B $2.164B
YoY Change 25.99% 4.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $601.8M $536.1M
Total Long-Term Liabilities $2.211B $2.164B
Total Liabilities $2.813B $2.700B
YoY Change 4.41% 2.27%
SHAREHOLDERS EQUITY
Retained Earnings $2.353B $2.163B
YoY Change 45.11% 45.25%
Common Stock $1.494B $1.538B
YoY Change -11.14% -11.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.844B $3.698B
YoY Change
Total Liabilities & Shareholders Equity $6.657B $6.398B
YoY Change 11.09% 9.0%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $210.3M $131.2M
YoY Change 40.31% -33.92%
Depreciation, Depletion And Amortization $179.7M $166.2M
YoY Change 13.82% 7.78%
Cash From Operating Activities $476.4M $276.0M
YoY Change 24.3% -16.78%
INVESTING ACTIVITIES
Capital Expenditures $322.7M $332.4M
YoY Change -18.96% 38.08%
Acquisitions
YoY Change
Other Investing Activities $5.000K -$77.00K
YoY Change -98.57% -74.92%
Cash From Investing Activities -$322.7M -$332.3M
YoY Change -18.89% 38.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.09M -$53.62M
YoY Change -17.61% -8.11%
NET CHANGE
Cash From Operating Activities 476.4M $276.0M
Cash From Investing Activities -322.7M -$332.3M
Cash From Financing Activities -70.09M -$53.62M
Net Change In Cash 83.62M -$109.9M
YoY Change -183.93% -434.37%
FREE CASH FLOW
Cash From Operating Activities $476.4M $276.0M
Capital Expenditures $322.7M $332.4M
Free Cash Flow $153.7M -$56.37M
YoY Change -1130.35% -161.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
7198000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84618000 usd
CY2024Q1 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
91816000 usd
CY2024Q1 us-gaap Assets
Assets
6398458000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
496361000 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
24108000 usd
CY2024Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1576115000 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
124085000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
397296000 usd
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1369000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
65258000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2164123000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115036144 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1150000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1536929000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2162771000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2599000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6398458000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
559596000 usd
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
2727000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
198552000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15615000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
506252000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
536084000 usd
CY2024Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115036144 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3698251000 usd
CY2024Q1 us-gaap Other Operating Income
OtherOperatingIncome
274000 usd
CY2024Q1 us-gaap Revenues
Revenues
559870000 usd
CY2023Q1 us-gaap Revenues
Revenues
573505000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
137375000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
142348000 usd
CY2024Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
166188000 usd
CY2023Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
154189000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
18581000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
18428000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30178000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27669000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-28145000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
51329000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1008000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-10153000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
381475000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
301458000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
178395000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
272047000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
21873000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
22459000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
6770000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
4702000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-232000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
163268000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
254058000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32069000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55506000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
131199000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
198552000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115642000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121671000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116456000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122294000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.63
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
131199000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
198552000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-8000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-13000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
131207000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
198565000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3615850000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
131199000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20707000 usd
CY2024Q1 sm Stock Issued During Period Value Restricted Stock Units
StockIssuedDuringPeriodValueRestrictedStockUnits
-22000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5018000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
33095000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3698251000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3085458000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18078000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4318000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
40468000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3229795000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
131199000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
198552000 usd
CY2024Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
166188000 usd
CY2023Q1 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
154189000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5018000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4318000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-28145000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
51329000 usd
CY2024Q1 sm Cash Portion Of Gain Loss On Derivative Instrument
CashPortionOfGainLossOnDerivativeInstrument
13274000 usd
CY2023Q1 sm Cash Portion Of Gain Loss On Derivative Instrument
CashPortionOfGainLossOnDerivativeInstrument
5076000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1371000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1371000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
27391000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
49968000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1102000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4295000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
97688000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
26216000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
276000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
331634000 usd
CY2024Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
332365000 usd
CY2023Q1 us-gaap Payments To Explore And Develop Oil And Gas Properties
PaymentsToExploreAndDevelopOilAndGasProperties
240712000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-77000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-307000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-332288000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-240405000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
32768000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40068000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
20834000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18290000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
22000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53624000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58358000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-109912000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32871000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
616164000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
444998000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
506252000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
506252000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
477869000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
32986000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
33882000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3292000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-50000 usd
CY2024Q1 sm Increase Decrease In Capital Expenditure Accruals And Other
IncreaseDecreaseInCapitalExpenditureAccrualsAndOther
-26569000 usd
CY2023Q1 sm Increase Decrease In Capital Expenditure Accruals And Other
IncreaseDecreaseInCapitalExpenditureAccrualsAndOther
66873000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
559596000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
570778000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
CY2022Q3 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2024-12-31
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
712000 shares
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1414000 shares
CY2024Q1 sm Stock Repurchase Program Shares Repurchased Weighted Average Price Per Share
StockRepurchaseProgramSharesRepurchasedWeightedAveragePricePerShare
45.99
CY2023Q1 sm Stock Repurchase Program Shares Repurchased Weighted Average Price Per Share
StockRepurchaseProgramSharesRepurchasedWeightedAveragePricePerShare
28.32
CY2024Q1 sm Stock Repurchased And Retired During Period Excluding Taxes Commission And Fees Value
StockRepurchasedAndRetiredDuringPeriodExcludingTaxesCommissionAndFeesValue
32753000 usd
CY2023Q1 sm Stock Repurchased And Retired During Period Excluding Taxes Commission And Fees Value
StockRepurchasedAndRetiredDuringPeriodExcludingTaxesCommissionAndFeesValue
40040000 usd
sm Stock Repurchased And Retired Since Inception Shares
StockRepurchasedAndRetiredSinceInceptionShares
9000000 shares
sm Stock Repurchased And Retired Since Inception Excluding Taxes Commission And Fees Value
StockRepurchasedAndRetiredSinceInceptionExcludingTaxesCommissionAndFeesValue
317900000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
182100000 usd
CY2022Q3 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2024-12-31
CY2024Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4254000 usd
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4998000 usd
CY2024Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
424000 usd
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
540000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
27391000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
49968000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32069000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55506000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.218
CY2024Q1 us-gaap Senior Notes
SeniorNotes
1576115000 usd
CY2023Q4 us-gaap Senior Notes
SeniorNotes
1575334000 usd
CY2024Q1 us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
The Company was in compliance with all financial and non-financial covenants as of March 31, 2024, and through the filing of this report.
CY2024Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
6100000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
5500000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
15600000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
57100000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
41111000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
65114000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
25477000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
8062000 usd
CY2024Q1 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
21519000 usd
CY2023Q4 us-gaap Derivative Asset Not Offset Policy Election Deduction
DerivativeAssetNotOffsetPolicyElectionDeduction
7362000 usd
CY2024Q1 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
21519000 usd
CY2023Q4 us-gaap Derivative Liability Not Offset Policy Election Deduction
DerivativeLiabilityNotOffsetPolicyElectionDeduction
7362000 usd
CY2024Q1 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
19592000 usd
CY2023Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
57752000 usd
CY2024Q1 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
3958000 usd
CY2023Q4 us-gaap Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
700000 usd
CY2024Q1 sm Derivative Settlement Gain Or Loss
DerivativeSettlementGainOrLoss
-13274000 usd
CY2023Q1 sm Derivative Settlement Gain Or Loss
DerivativeSettlementGainOrLoss
-5076000 usd
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-28145000 usd
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
51329000 usd
CY2024Q1 sm Percentageof Proved Property Securedfor Credit Facility Borrowing
PercentageofProvedPropertySecuredforCreditFacilityBorrowing
0.85
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
131199000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
198552000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115642000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121671000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
814000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
623000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116456000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122294000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.63
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62

Files In Submission

Name View Source Status
0000893538-24-000030-index-headers.html Edgar Link pending
0000893538-24-000030-index.html Edgar Link pending
0000893538-24-000030.txt Edgar Link pending
0000893538-24-000030-xbrl.zip Edgar Link pending
exhibit311certificationhvo.htm Edgar Link pending
exhibit312certificationwpu.htm Edgar Link pending
exhibit321906certification.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sm-20240331.htm Edgar Link pending
sm-20240331.xsd Edgar Link pending
sm-20240331_g1.jpg Edgar Link pending
sm-20240331_def.xml Edgar Link unprocessable
sm-20240331_lab.xml Edgar Link unprocessable
sm-20240331_pre.xml Edgar Link unprocessable
sm-20240331_htm.xml Edgar Link completed
sm-20240331_cal.xml Edgar Link unprocessable